Global Neuromodulation in Epilepsy Market is Expected to Reach US$ 3410.12 Million by 2027, Growing at an Estimated CAGR of 10.71% Over the Forecast Period Owing to Continuous Growth in Technology and Application Frontiers

PUNE, India, Dec. 11, 2019 /PRNewswire/ --  The primary advantage of neuromodulation is that it does not involve lesioning brain tissue and the physician can titrate electric therapy akin to managing medication dosage which has lead to development of this neuromodulation in epilepsy market. A new neurostimulator has been developed by engineers at the University of California that delivers exceptionally advantageous results for patients suffering from epilepsy and Parkinson's disease. The device named "WAND" works just like a pacemaker for brain that monitors the brain's electrical activity and delivers electrical stimulation.

Request for Sample Copy of This Report@ https://www.absolutemarketsinsights.com/request_sample.php?id=276 

These devices proves to be an effective solution in preventing debilitating tremors in patients. However, the electrical signatures that precede a seizure can be extremely subtle in nature. In addition, it can take years of small adjustments by doctors before the devices provide an optimal treatment. As compared to wireless artifact-free neuromodulation (WAND) device, the existing devices can record signals from the smaller brain waves and are extremely sensitive to large stimulation pulses. In the future years, the researchers aim to incorporate learning into closed-loop platform to build intelligent devices for treatment purpose.

The detailed research study provides qualitative and quantitative analysis of neuromodulation in epilepsy market. The market has been analyzed from demand as well as supply side. The demand side analysis covers market revenue across regions and further across all the major countries. The supply side analysis covers the major market players and their regional and global presence and strategies. The geographical analysis done emphasizes on each of the major countries across North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

Enquiry Before Buying @ https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=276 

Key Findings of the Report:

• In terms of revenue, global neuromodulation in epilepsy market is expected to reach USD 3410.12 million by 2027, growing at an estimated CAGR of 10.71% over the next eight years owing to the technological advancements led by researchers.
• Deep Brain Stimulation (DBS) segment has the highest penetration in 2018 as it helps the adults that have not responded to medications and those who are not meant for any other surgical procedures
• In DBS, a device is implanted, that sends signal to brain areas that are responsible for body movement. The benefits of the surgery are better sleep, more involvement in physical activity, and improved quality of life.
• Single Pulse involves placing the pulse device against the back of the head for less than a second to deliver a very brief pre-set magnetic pulse. This segment is expected to witness the highest growth over the forecast period due to safe, non-invasive and non-drug treatment.
• Asia Pacific neuromodulation in epilepsy market is projected to witness the highest CAGR of 11.97% over the next eight years. China dominated the market due to increased interest in neuromodulation owing to emerging valuable tools such as vagus nerve stimulation (VNS), deep-brain stimulation (DBS) and responsive neurostimulation (RNS).  
• Some of the players operating in the neuromodulation in epilepsy market are Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Medtronic, NeuroPace, Inc. amongst others

Request for Customization@ https://www.absolutemarketsinsights.com/request_for_customization.php?id=276 

Key Market Segments of neuromodulation in epilepsy market :

• By Therapy Type
• Vagus Nerve Stimulation (VNS)
• Deep Brain Stimulation (DBS)
• By Magnetic Stimulation Technique
• Single pulse
• Repeated pulse 
• By Geography
• North America
• U.S.
• Canada
• Mexico
• Rest of North America
• Europe
• France
• The UK
• Spain
• Germany
• Italy
• Nordic Countries
• Denmark
• Finland
• Iceland
• Norway
• Sweden
• Benelux Union
• Belgium
• The Netherlands
• Luxemburg
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia Pacific
• Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Purchase the Premium Report@ https://www.absolutemarketsinsights.com/checkout?id=276 

About Us:

Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization.

From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.

Contact Us:

Company: Absolute Markets Insights
Email id: [email protected] 
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
The Work Lab, 
Model Colony, Shivajinagar, Pune, MH, 411016
Website: https://www.absolutemarketsinsights.com/

Follow Us on Social Media:

https://www.facebook.com/AbsoluteMarketsInsights/ 
https://twitter.com/AbsoluteMI 
https://www.linkedin.com/company/absolute-markets-insights/ 
https://plus.google.com/117657938830005040584 

SOURCE Absolute Markets Insights